Quarterly Result11 Aug 2026, 05:21 pm
Beryl Drugs declares Q1 FY27 unaudited financial results
AI Summary
Beryl Drugs Ltd announced its unaudited financial results for the quarter ended June 30, 2026. The Board of Directors approved these results in a meeting held on August 11, 2026. The results are prepared in accordance with Indian accounting standards and SEBI regulations. The company operates in a single segment, the Pharmaceutical Industry. Figures for previous periods have been reclassified where necessary for comparability.
Key Highlights
- Unaudited financial results for Q1 FY27 declared.
- Board of Directors approved results on August 11, 2026.
- Results prepared as per Indian accounting standards.
- Company operates in the Pharmaceutical Industry segment.
- Previous period figures were reclassified for consistency.
Price Impact
More from BERLDRG